Market Closed -
Nasdaq
04:00:00 2024-05-28 pm EDT
|
5-day change
|
1st Jan Change
|
17.28
USD
|
-0.17%
|
|
+7.00%
|
-24.97%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,755
|
2,596
|
2,719
|
2,065
|
-
|
-
|
Enterprise Value (EV)
1 |
2,467
|
2,248
|
2,330
|
1,643
|
1,505
|
1,388
|
P/E ratio
|
-14.1
x
|
-284
x
|
121
x
|
90.1
x
|
59
x
|
48.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.85
x
|
1.91
x
|
1.64
x
|
1.24
x
|
1.1
x
|
0.96
x
|
EV / Revenue
|
2.55
x
|
1.66
x
|
1.41
x
|
0.99
x
|
0.8
x
|
0.65
x
|
EV / EBITDA
|
59.6
x
|
36.9
x
|
32.3
x
|
18.8
x
|
14.3
x
|
11
x
|
EV / FCF
|
45.3
x
|
47.7
x
|
28.9
x
|
23.4
x
|
16.4
x
|
12.2
x
|
FCF Yield
|
2.21%
|
2.1%
|
3.46%
|
4.28%
|
6.09%
|
8.19%
|
Price to Book
|
6.44
x
|
5.22
x
|
5.11
x
|
3.31
x
|
3.07
x
|
2.53
x
|
Nbr of stocks (in thousands)
|
106,499
|
114,299
|
118,064
|
119,318
|
-
|
-
|
Reference price
2 |
25.87
|
22.71
|
23.03
|
17.28
|
17.28
|
17.28
|
Announcement Date
|
3/22/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
817.1
|
966.2
|
1,357
|
1,658
|
1,661
|
1,872
|
2,147
|
EBITDA
1 |
-
|
41.38
|
60.85
|
72.23
|
87.34
|
105.2
|
126.7
|
EBIT
1 |
-
|
-217.4
|
-19.12
|
20.65
|
21.31
|
39.92
|
52.59
|
Operating Margin
|
-
|
-22.5%
|
-1.41%
|
1.25%
|
1.28%
|
2.13%
|
2.45%
|
Earnings before Tax (EBT)
1 |
-
|
-218.5
|
-18.58
|
29.02
|
30.45
|
46.93
|
59.23
|
Net income
1 |
-
|
-188.2
|
-8.585
|
23.08
|
23.83
|
36.37
|
47.6
|
Net margin
|
-
|
-19.48%
|
-0.63%
|
1.39%
|
1.43%
|
1.94%
|
2.22%
|
EPS
2 |
0.3300
|
-1.830
|
-0.0800
|
0.1900
|
0.1918
|
0.2930
|
0.3544
|
Free Cash Flow
1 |
-
|
54.51
|
47.09
|
80.67
|
70.25
|
91.71
|
113.8
|
FCF margin
|
-
|
5.64%
|
3.47%
|
4.87%
|
4.23%
|
4.9%
|
5.3%
|
FCF Conversion (EBITDA)
|
-
|
131.74%
|
77.39%
|
111.69%
|
80.44%
|
87.17%
|
89.77%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
349.55%
|
294.83%
|
252.17%
|
238.96%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/17/21
|
3/22/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
275.3
|
313.8
|
335.5
|
342.9
|
364.4
|
386.3
|
413.4
|
417.3
|
440.8
|
415.2
|
410.5
|
413.6
|
425.6
|
467.2
|
467.7
|
EBITDA
1 |
7.528
|
14.8
|
15.53
|
15.65
|
14.26
|
16.86
|
19.31
|
18.77
|
17.28
|
19.92
|
21.76
|
23.09
|
22.5
|
23.94
|
25.95
|
EBIT
1 |
-19.35
|
-11.55
|
-5.25
|
-4.574
|
2.249
|
6.714
|
6.979
|
5.536
|
1.42
|
0.823
|
5.855
|
7.351
|
5.998
|
6.116
|
9.581
|
Operating Margin
|
-7.03%
|
-3.68%
|
-1.56%
|
-1.33%
|
0.62%
|
1.74%
|
1.69%
|
1.33%
|
0.32%
|
0.2%
|
1.43%
|
1.78%
|
1.41%
|
1.31%
|
2.05%
|
Earnings before Tax (EBT)
1 |
-19.53
|
-11.78
|
-5.913
|
-4.289
|
3.401
|
8.527
|
7.796
|
8.43
|
4.268
|
3.807
|
7.355
|
8.82
|
7.447
|
7.783
|
11.25
|
Net income
1 |
-11.98
|
-17.51
|
-10.48
|
1.624
|
17.78
|
7.324
|
7.274
|
5.643
|
2.838
|
2.984
|
6.343
|
7.285
|
6.332
|
6.554
|
9.186
|
Net margin
|
-4.35%
|
-5.58%
|
-3.12%
|
0.47%
|
4.88%
|
1.9%
|
1.76%
|
1.35%
|
0.64%
|
0.72%
|
1.55%
|
1.76%
|
1.49%
|
1.4%
|
1.96%
|
EPS
2 |
-0.1100
|
-0.1600
|
-0.1000
|
0.0100
|
0.1400
|
0.0600
|
0.0600
|
0.0500
|
0.0200
|
0.0200
|
0.0509
|
0.0603
|
0.0532
|
0.0627
|
0.0767
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/22/22
|
5/12/22
|
8/11/22
|
11/10/22
|
2/28/23
|
5/4/23
|
8/3/23
|
11/3/23
|
2/27/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
288
|
348
|
390
|
423
|
561
|
677
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
54.5
|
47.1
|
80.7
|
70.3
|
91.7
|
114
|
ROE (net income / shareholders' equity)
|
-
|
-65.6%
|
-1.85%
|
4.35%
|
4.36%
|
4.61%
|
4.13%
|
ROA (Net income/ Total Assets)
|
-
|
-37.1%
|
-1.16%
|
2.57%
|
2.82%
|
3.48%
|
-
|
Assets
1 |
-
|
507.7
|
739.6
|
896.4
|
845.9
|
1,046
|
-
|
Book Value Per Share
2 |
-
|
4.020
|
4.350
|
4.500
|
5.220
|
5.630
|
6.830
|
Cash Flow per Share
2 |
-
|
0.5300
|
0.4300
|
0.6500
|
0.5100
|
0.7200
|
-
|
Capex
1 |
-
|
0.55
|
0.1
|
0.11
|
0.71
|
0.93
|
1.26
|
Capex / Sales
|
-
|
0.06%
|
0.01%
|
0.01%
|
0.04%
|
0.05%
|
0.06%
|
Announcement Date
|
3/17/21
|
3/22/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
17.28
USD Average target price
25.64
USD Spread / Average Target +48.37% Consensus |
1st Jan change
|
Capi.
|
---|
| -24.97% | 2.07B | | +17.73% | 83.47B | | -32.08% | 69.72B | | -3.24% | 26.37B | | +4.13% | 17.86B | | -13.68% | 16.83B | | +0.75% | 15.7B | | +74.92% | 13.45B | | +73.16% | 12.81B | | -2.02% | 12.44B |
Other Healthcare Facilities & Services
|